In July, the US Food and Drug Administration (FDA) approved a new blood-based test to screen for colorectal cancer (CRC). The FDA's approval of Shield (Guardant Health) marks a notable achievement, as ...
Increased time spent on discussing testing for colorectal cancer (CRC) was associated with patient satisfaction in older adults. Adults aged 76 to 85 years were more likely to continue testing for ...
Multigene panel testing should be considered for all patients with colorectal cancer (CRC) who are diagnosed younger than age 50 years, new findings suggest. Among 450 patients with early-onset CRC, ...
Approval expands colorectal cancer screening options for the up to 60 million Americans who are overdue for screening – – Medicare coverage and ...
Freenome retains rights to its CRC blood test when combined with other cancer screening tests. Credit: PeopleImages.com - Yuri A / Shutterstock.com. · Medical Device Network · PeopleImages.com - Yuri ...
Dr Kristen Ciombor discusses utilization of biomarkers and molecular testing in the treatment of patients with CRC. Kristen Ciombor, MD: In terms of molecular testing for colorectal cancer, in early ...
A patient who had repeatedly refused routine screening for colorectal cancer (CRC), despite having lost his 80-year-old father to the disease, was again advised to undergo a colonoscopy at age 56. He ...
Cologuard® CRC Screening Test Most Cost-Effective Test in Medically Underserved Alaska Native People
MADISON, Wis., April 28, 2021 /PRNewswire/ -- Exact Sciences (NASDAQ: EXAS) today announces study results published in Mayo Clinic Proceedings showing that Cologuard (mt-sDNA) is the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results